Filing Details
- Accession Number:
- 0001209191-23-018952
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-15 17:20:08
- Reporting Period:
- 2023-03-14
- Accepted Time:
- 2023-03-15 17:20:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1176309 | Oramed Pharmaceuticals Inc. | ORMP | Pharmaceutical Preparations (2834) | 980376008 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1409232 | Miriam Kidron | 2 Elza Street Jerusalem L3 93706 | Chief Scientific Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-14 | 100,000 | $2.01 | 201,666 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment.
Billionaire Hedge Funds
